142563-76-6

Basic information

• Product Name: 1D-1-O-(tert-butyldiphenylsilyl)-4-O-(trimethylacetyl)-2,3-O-(D-1',7',7'-trimethyl<2.2.1>bicyclohept-2'-ylidene)-myo-inositol
• Synonyms: 1D-1-O-(tert-butyldiphenylsilyl)-4-O-(trimethylacetyl)-2,3-O-(D-1',7',7'-trimethyl<2.2.1>bicyclohept-2'-ylidene)-myo-inositol
• CAS NO: 142563-76-6
• Molecular Weight: 636.901
• Mol File: 142563-76-6.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 1D-1-O-(tert-butyldiphenylsilyl)-4-O-(trimethylacetyl)-2,3-O-(D-1',7',7'-trimethyl<2.2.1>bicyclohept-2'-ylidene)-myo-inositol(CAS DataBase Reference)
• NIST Chemistry Reference: 1D-1-O-(tert-butyldiphenylsilyl)-4-O-(trimethylacetyl)-2,3-O-(D-1',7',7'-trimethyl<2.2.1>bicyclohept-2'-ylidene)-myo-inositol(142563-76-6)
• EPA Substance Registry System: 1D-1-O-(tert-butyldiphenylsilyl)-4-O-(trimethylacetyl)-2,3-O-(D-1',7',7'-trimethyl<2.2.1>bicyclohept-2'-ylidene)-myo-inositol(142563-76-6)

Safety Data

• Hazardous Substances Data: 142563-76-6(Hazardous Substances Data)

Upstream product

• 142534-51-8 C₄₂H₆₀O₉Si₂ 
• 128459-27-8 1D-2,3-O-(D-1',7',7'-trimethyl<2.2.1>bicyclohept-2'-ylidene)-myo-inositol 
• 109280-15-1 (1R)-(+)-camphor dimethyl acetal 
• 87-89-8 D-myo-inositol 
• 3282-30-2 pivaloyl chloride 
• 142534-33-6 1D-1-O-(tert-butyldiphenylsilyl)-2,3-O-(D-1',7',7'-trimethyl<2.2.1>bicyclohept-2'-ylidene)-myo-inositol 

Downstream Products

• 142534-43-8 1D-1-O-(tert-butyldiphenylsilyl)-6-O-(methoxymethylene)-2,3-O-(D-1',7',7'-trimethyl<2.2.1>bicyclohept-2'-ylidene)-myo-inositol 
• 142534-35-8 1D-1-O-(tert-butyldiphenylsilyl)-6-O-(methoxymethylene)-4-O-(trimethylacetyl)-2,3-O-(D-1',7',7'-trimethyl<2.2.1>bicyclohept-2'-ylidene)-myo-inositol 
• 142534-36-9 1D-5,6-O-bis(methoxymethylene)-1-O-(tert-butyldiphenylsilyl)-4-O-(trimethylacetyl)-2,3-O-(D-1',7',7'-trimethyl<2.2.1>bicyclohept-2'-ylidene)-myo-inositol 

Relevant articles and documents

Efficient and systematic syntheses of enantiomerically pure and regiospecifically protected myo-inositols

Efficient and systematic syntheses of a variety of enantiomerically pure and regiospecifically protected myo-inositols, which can be readily used as precursors for most natural and unnatural derivatives of myo-inositol, have been developed. The key strate